Department of Psychiatry and Psychotherapy, Lübeck University, Lübeck, Germany.
Department of Psychiatry, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
J Affect Disord. 2018 Mar 15;229:262-268. doi: 10.1016/j.jad.2017.12.091. Epub 2018 Jan 4.
Persistent depressive disorder (PDD) is associated with high rates of comorbid personality disorders (PD). The association of comorbid PD and clinical characteristics has not been systematically studied in PDD. Results regarding effects on treatment outcome are heterogeneous.
We analyzed the association of comorbid personality disorders with clinical characteristics and outcome in a randomized controlled trial comparing the disorder-specific Cognitive Behavioral Analysis System of Psychotherapy (CBASP) with nonspecific supportive psychotherapy (SP) in patients with early-onset PDD. The main outcome measure was the Hamilton Rating Scale for Depression (HRSD-24). Further baseline measures were comorbid axis-I diagnoses (SCID-I), quality of life (QLDS), global functioning (GAF), interpersonal problems (IIP-64) and childhood maltreatment (CTQ).
Out of the 268 patients, 103 (38.4%) met criteria for at least one PD. PD was associated with higher rates of axis I comorbidities (mainly anxiety disorders) and interpersonal problems (patients with PD were more vindictive, more self-sacrificing, less assertive and more inhibited socially than patients without PD). There was no significant main effect of PD on treatment outcome and no significant interaction between PD and treatment group.
The main limitation was the exclusion of patients with certain personality disorders (antisocial, schizotypal, and borderline personality disorders). Furthermore, the study was underpowered to find interaction effects of small size.
Persistently depressed patients with and without comorbid PD primarily seemed to differ in the rate of axis I comorbidity and the severity of interpersonal problems. Treatment outcomes appear to be not significantly affected by the presence of PD.
持续性抑郁障碍(PDD)与较高的共患人格障碍(PD)率有关。共患 PD 与临床特征的关联尚未在 PDD 中得到系统研究。关于对治疗结果的影响的结果是多种多样的。
我们分析了在一项随机对照试验中,共患人格障碍与临床特征和结果的关联,该试验比较了特定于障碍的认知行为分析系统心理治疗(CBASP)与非特异性支持性心理治疗(SP)在早期发作的 PDD 患者中的疗效。主要结局指标是汉密尔顿抑郁评定量表(HRSD-24)。进一步的基线测量包括共患轴 I 诊断(SCID-I)、生活质量(QLDS)、总体功能(GAF)、人际关系问题(IIP-64)和儿童期虐待(CTQ)。
在 268 名患者中,有 103 名(38.4%)符合至少一种 PD 的标准。PD 与较高的轴 I 共病率(主要是焦虑障碍)和人际关系问题(PD 患者比无 PD 患者更报复心强、更自我牺牲、更不果断、更社交抑制)有关。PD 对治疗结果没有显著的主要影响,也没有 PD 和治疗组之间的显著相互作用。
主要限制是排除了某些人格障碍(反社会、精神分裂型和边缘型人格障碍)的患者。此外,该研究的效力不足以发现较小的交互作用效果。
患有和不患有共患 PD 的持续性抑郁患者主要在轴 I 共病率和人际关系问题的严重程度上似乎有所不同。治疗结果似乎没有受到 PD 存在的显著影响。